Clara Bloomfield, blood cancer expert and destroyer of glass ceilings, dies at 77

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

In 1989, I joined Cancer and Leukemia Group B and was introduced into the clinical trials world and a mighty force for good, Dr. Clara D. Bloomfield.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Electra D. Paskett, PhD
Marion N. Rowley Professor of Cancer Research, director, Division of Cancer Prevention and Control, Department of Internal Medicine, professor, Division of Epidemiology, College of Public Health, associate director, population sciences and community outreach, Comprehensive Cancer Center, director, Center for Cancer Health Equity, Ohio State University
Table of Contents

YOU MAY BE INTERESTED IN

People of African ancestry (Black/African American) have some of the worst cancer incidence and greatest mortality, compared to white and other racial and ethnic populations in the U.S. On average, Black persons are 1.5 times more likely to have cancer and >2X more likely to die from cancer compared to whites. xxx:more
Electra D. Paskett, PhD
Marion N. Rowley Professor of Cancer Research, director, Division of Cancer Prevention and Control, Department of Internal Medicine, professor, Division of Epidemiology, College of Public Health, associate director, population sciences and community outreach, Comprehensive Cancer Center, director, Center for Cancer Health Equity, Ohio State University

Login